Cargando…
518. Characterization of colistin-resistant (COL-R) Acinetobacter baumannii calcoaceticus complex (ABC) isolates from a recent, global Phase 3 trial (ATTACK)
BACKGROUND: Due to the lack of effective therapies, last-resort agents such as colistin are more frequently being used to treat drug-resistant ABC infections. Consequently, COL-R ABC is becoming more common, with some countries such as Greece reporting rates of >50%(1). The efficacy and safety of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752379/ http://dx.doi.org/10.1093/ofid/ofac492.573 |